Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer.
about
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literaturePeritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsMolecular targeting to treat gastric cancer.Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis.Molecular background of the regional lymph node metastasis of gastric cancer.
P2860
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Molecular targeting therapy us ...... etastasis from gastric cancer.
@en
type
label
Molecular targeting therapy us ...... etastasis from gastric cancer.
@en
prefLabel
Molecular targeting therapy us ...... etastasis from gastric cancer.
@en
P2093
P2860
P356
P1476
Molecular targeting therapy us ...... etastasis from gastric cancer.
@en
P2093
Junya Kizaki
Kazuo Shirouzu
Keishiro Aoyagi
Kikuo Kouhuji
Kousuke Hashimoto
Motoshi Miyagi
Taro Isobe
P2860
P356
10.5492/WJCCM.V2.I4.48
P577
2013-11-04T00:00:00Z